Data from Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer
Approximately one-third of endocrine-treated women with estrogen receptor alpha–positive (ER+) breast cancers are at risk of recurrence due to intrinsic or acquired resistance. Thus, it is vital to understand the mechanisms underlying endocrine therapy resistance in ER+ breast cancer to improve patient treatment. Mitochondrial fatty acid β-oxidation (FAO) has been shown to be a major metabolic pathway in triple-negative breast cancer (TNBC) that can activate Src signaling. Here, we found metabolic reprogramming that increases FAO in ER+ breast cancer as a mechanism of resistance to endocrine therapy. A metabolically relevant, integrated gene signature was derived from transcriptomic, metabolomic, and lipidomic analyses in TNBC cells following inhibition of the FAO rate-limiting enzyme carnitine palmitoyl transferase 1 (CPT1), and this TNBC-derived signature was significantly associated with endocrine resistance in patients with ER+ breast cancer. Molecular, genetic, and metabolomic experiments identified activation of AMPK-FAO-oxidative phosphorylation (OXPHOS) signaling in endocrine-resistant ER+ breast cancer. CPT1 knockdown or treatment with FAO inhibitors in vitro and in vivo significantly enhanced the response of ER+ breast cancer cells to endocrine therapy. Consistent with the previous findings in TNBC, endocrine therapy–induced FAO activated the Src pathway in ER+ breast cancer. Src inhibitors suppressed the growth of endocrine-resistant tumors, and the efficacy could be further enhanced by metabolic priming with CPT1 inhibition. Collectively, this study developed and applied a TNBC-derived signature to reveal that metabolic reprogramming to FAO activates the Src pathway to drive endocrine resistance in ER+ breast cancer.
Significance:Increased fatty acid oxidation induced by endocrine therapy activates Src signaling to promote endocrine resistance in breast cancer, which can be overcome using clinically approved therapies targeting FAO and Src.
CITE THIS COLLECTION
FUNDING
National Cancer Institute (NCI)
United States Department of Health and Human Services
U.S. Department of Defense (DOD)
Cancer Prevention and Research Institute of Texas (CPRIT)
National Institute of Environmental Health Sciences (NIEHS)
United States Department of Health and Human Services
National Institute on Minority Health and Health Disparities (NIMHD)
United States Department of Health and Human Services
National Institute of Mental Health (NIMH)
United States Department of Health and Human Services
Breast Cancer Research Foundation (BCRF)
SHARE
Usage metrics
Read the peer-reviewed publication

AUTHORS (11)
- SASongyeon AhnJPJun Hyoung ParkSGSandra L. GrimmDPDanthasinghe Waduge Badrajee PiyarathnaTSTagari SamantaVPVasanta PutluriDMDereck MezquitaSFSuzanne A.W. FuquaNPNagireddy PutluriCCCristian CoarfaBKBenny Abraham Kaipparettu